Share

Vogt, Annabelle de

List of all publications

Publishing since 2007 (Baby)

    2010

  1. Journal Article Raskopf E, Vogt A, Standop J, Sauerbruch T, Schmitz V. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.  Z Gastroenterol  2010;48;1  Link to Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.

    2. 2009

  2. Journal Article Krämer B, Schulte D, Körner C, Zwank C, Hartmann A, Michalk M, Söhne J, Langhans B, Nischalke HD, Coenen M, Möhl C, Vogt A, Hennenberg M, Sauerbruch T, Spengler U, Nattermann J. Regulation of NK cell trafficking by CD81.  Eur. J. Immunol.  2009;39;12  Link to Regulation of NK cell trafficking by CD81.
  3. Journal Article Raskopf E, Gerceker S, Vogt A, Standop J, Sauerbruch T, Schmitz V. Plasminogen fragment K1-3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver.  Int J Colorectal Dis  2009;24;7  Link to Plasminogen fragment K1-3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver.
  4. Journal Article Quante M, Raskopf E, Stahl S, Vogt A, Sauerbruch T, Schmitz V. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.  Oncol. Rep.  2009;21;5  Link to No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.

    5. 2008

  5. In VitroJournal Article Raskopf E, Vogt A, Sauerbruch T, Schmitz V. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.  J. Hepatol.  2008;49;6  Link to siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
  6. Journal Article Gonzalez-Carmona MA, Lukacs-Kornek V, Timmerman A, Shabani S, Kornek M, Vogt A, Yildiz Y, Sievers E, Schmidt-Wolf IG, Caselmann WH, Sauerbruch T, Schmitz V. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.  Hepatology  2008;48;1  Link to CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
  7. Journal Article Schmitz V, Raskopf E, Gonzalez-Carmona MA, Vogt A, Kornek M, Sauerbruch T, Caselmann WH. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.  Cancer Invest.  2008;26;5  Link to Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.

    8. 2007

  8. Journal Article Schmitz V, Raskopf E, Gonzalez-Carmona MA, Vogt A, Rabe C, Leifeld L, Kornek M, Sauerbruch T, Caselmann WH. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.  Gut  2007;56;2  Link to Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.
Back to page of Vogt, Annabelle.

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.